Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study

Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study

BackgroundHepatoma arterial-embolization prognostic (HAP) series scores have been proposed for prognostic prediction in patients with unresectable hepatocellular carcinoma (uHCC) undergoing transarterial chemoembolization (TACE). However, their prognostic value in TACE plus sorafenib (TACE-S) remain...

Full description

Bibliographic Details
Main Authors: Yejing Zhu, Enxin Wang, Shoujie Zhao, Dandan Han, Yan Zhao, Hui Chen, Jun Zhu, Tenghui Han, Yang Bai, Yanju Lou, Yongchao Zhang, Man Yang, Luo Zuo, Jiahao Fan, Xing Chen, Jia Jia, Wenbin Wu, Weirong Ren, Tingting Bai, Shouzheng Ma, Fenghua Xu, Yuxin Tang, Ying Han, Junlong Zhao, Xingshun Qi, Jing Li, Xilin Du, Dongfeng Chen, Lei Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
transarterial chemoembolization
sorafenib
HAP series scores
predictive value
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.983554/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.983554/full

Similar Items